Evidence map›Paper›PMID 42507486›Full record

ArticleNucleic acids research2026

mRNA cap formation by the human respiratory syncytial virus large protein.

Dean E Watkins, Kate Carpenter, Tiffany Yu, Minako Ogino, Tomoaki Ogino

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dean E WatkinsDepartment of Medical Microbiology and Immunology, College of Medicine and Life Sciences, University of Toledo, Toledo, OH 43614, United States.
Kate CarpenterDepartment of Medical Microbiology and Immunology, College of Medicine and Life Sciences, University of Toledo, Toledo, OH 43614, United States.
Tiffany YuDepartment of Medical Microbiology and Immunology, College of Medicine and Life Sciences, University of Toledo, Toledo, OH 43614, United States.
Minako OginoDepartment of Medical Microbiology and Immunology, College of Medicine and Life Sciences, University of Toledo, Toledo, OH 43614, United States.
Tomoaki OginoDepartment of Medical Microbiology and Immunology, College of Medicine and Life Sciences, University of Toledo, Toledo, OH 43614, United States.ORCID 0000-0002-4154-1781

Funding

mRNA synthesis and capping in nonsegmented negative strand RNA virusesR01AI093569 · NIAID · CLEVELAND CLINIC LERNER COM-CWRU · PI OGINO, TOMOAKI · 2012 to 2016
$1.8M
Dissecting catalytic and regulatory functions of nonsegmented negative strandRNA viral polymerasesR01AI146172 · NIAID · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI OGINO, TOMOAKI · 2019 to 2023
$1.8M
NIAID NIH HHS R01 AI093569NIAID NIH HHS R01 AI146172NIH HHS AI093569NIH HHS AI146172University of Toledo
6 · The paper itself

Abstract

The mechanisms underlying mRNA capping in non-segmented negative-strand RNA viruses, except rhabdoviruses, remain elusive. Here, we demonstrate that the RNA-dependent RNA polymerase (RdRp), composed of the large protein (L) and the phosphoprotein (P), of human respiratory syncytial virus (HRSV, a pneumovirus) catalyzes capping through GDP polyribonucleotidyltransferase (PRNTase) activity, which transfers 5'-monophosphorylated RNA (pRNA) from 5'-triphosphorylated RNA to GDP via a putative covalent L-pRNA intermediate. The HR motif (motif D) on the catalytic loop of the L PRNTase domain is critical for capping, whereas the GxxT sequence in motif B is dispensable, unlike in rhabdoviruses. The capping activity is inhibited at the intermediate formation step by JNJ-8003, an antiviral compound that binds a cleft between motifs D and E. Pneumovirus-specific residues in the HRSV counterpart of the rhabdovirus priming-capping loop are not essential for either capping or de novo RNA synthesis initiation, although a di-lysine sequence is required for efficient capping. The L-P complex preferentially methylates the cap core at the guanine-N7 position and then methylates cap 0 at the 2'-O position, forming cap 1, in direct contrast to the methylation order observed in rhabdoviruses. Thus, the L enzymatic domains exhibit common and virus-specific properties in cap formation among pneumoviruses and rhabdoviruses.

Indexed as

PhosphoproteinsRespiratory Syncytial Virus, HumanRNA CapsRNA-Dependent RNA PolymeraseRNA, MessengerViral ProteinsAmino Acid MotifsHumansRNA, ViralViral Structural ProteinsPhosphoproteinsP protein, human respiratory syncytial virusRNA CapsRNA-Dependent RNA PolymeraseRNA, MessengerRNA, ViralViral ProteinsViral Structural Proteins

Identifiers

PMID42507486
PMCPMC13403909

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.